Integer Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Integer Holdings in the third quarter 2026?
Integer Holdings Corporation achieved a return on average equity (ROE) of 6.02 % in its third quarter 2026, this is above ITGR's average return on equity of 5.73%.
Integer Holdings Corporation shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $1,722 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 50 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1524 to 1655.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Oct 02 2026) III. Quarter	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 26 2025) III. Quarter
Y / Y Equity Change	-1.11 %	0.89 %	5.61 %	7.87 %	-
Y / Y Net Income Change	-62.25 %	-36.22 %	-	48.63 %	11.96 %
Net Income (TTM) in Millions	104	128	142	103	87
Return On Equity (TTM)	6.02 %	7.43 %	8.23 %	6.05 %	5.21 %
ITGR's Total Ranking	# 1655	# 1524	# 1372	# 786	#
Equity (TTM) in Millions	1,726	1,719	1,697	1,747	1,746
Seq. Equity Change	0.45 %	1.29 %	-2.85 %	0.05 %	2.48 %
Seq. Net Income Change	-36.55 %	43.01 %	-66.04 %	22.51 %	7.21 %

Back to ITGR Management Effectiveness >> ITGR's 5 Years Annual ROE >> Compare ITGR ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 51
Sector	# 161
Overall	# 1655

Return On Equity Statistics
High	Average	Low
12.46 %	5.73 %	-5.19 %
(Jun 29 2018)		(Jul 01 2016)

ITGR Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,747	1,619	1,519	1,417	1,355
Y / Y Equity Change	7.87 %	6.59 %	7.17 %	4.63 %	6.58 %
Net Income in Millions	103	120	91	66	97
Y / Y Net Income Change	-14.25 %	32.26 %	36.57 %	-31.43 %	25.3 %
Return On Equity	5.89 %	7.4 %	5.97 %	4.68 %	7.15 %

Back to ITGR Management Effectiveness >> ITGR's 5 Years Annual ROE >> Compare ITGR ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 5.89 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ITGR's' Return on Equity at Yahoo Finance
ITGR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ITGR's Competitors
Subscribers only: Roe for Integer Holdings's Suppliers
Subscribers only: Return On Equity for ITGR's Customers

Companies with similar Return On Equity at Oct 02 2026, within Healthcare Sector	ROE
Lemaitre Vascular Inc	15.81 %
Stryker Corp	15.61 %
Quest Diagnostics Inc	15.22 %
Regeneron Pharmaceuticals Inc	15.07 %
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Abbott Laboratories	9.00 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %

Date modified: 2026-10-30T13:14:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.